LGI1 antibody encephalitis: acute treatment comparisons and outcome

OBJECTIVE: To compare acute treatment responses and long-term outcome in leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis. METHODS: Retrospective case series of 118 patients with LGI1 antibody encephalitis evaluated at Mayo Clinic across all US sites from 1 May 2008 to 31 March 2019. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Andrew, Klein, C J, Sechi, Elia, Alden, Eva, Basso, Michael R, Pudumjee, Shehroo, Pittock, Sean J, McKeon, Andrew, Britton, Jeffrey W, Lopez-Chiriboga, A Sebastian, Zekeridou, Anastasia, Zalewski, Nicholas L, Boeve, B F, Day, Gregory S, Gadoth, Avi, Burkholder, David, Toledano, Michel, Dubey, Divyanshu, Flanagan, Eoin P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neuro-Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862031/
https://www.ncbi.nlm.nih.gov/pubmed/34824144
http://dx.doi.org/10.1136/jnnp-2021-327302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862031/
https://www.ncbi.nlm.nih.gov/pubmed/34824144
http://dx.doi.org/10.1136/jnnp-2021-327302

Ejemplares similares